Industry Advisory Council

Rosanna Ricafort, MD

Clinical Program Lead for Hematology-Oncology Research Development
Bristol-Myers Squibb

Rosanna Ricafort, MD

Rosanna Ricafort is a pediatric hematologist/oncologist and the Clinical Program Lead for Hematology-Oncology Clinical Development at Bristol-Myers Squibb Company, responsible for the late phase development of hematology assets both immuno-oncology (IO) and non-IO. Her team drives individual asset strategies from design through execution of specific data generation trials, including registrational, non-registrational, external collaborations and other business development activities. She is a core member of the Hematology Development Team, focused on the vision and growth of Oncology asset development strategies, including consideration for scientific, regulatory and clinical activities. Prior to this role at BMS, Rosanna’s industry career since 2013 consisted of increasing leadership positions in the US Medical Affairs organizations at BMS and Celgene, delivering 4 successful launches for 4 different immuno-oncology assets across disease indications in hematologic malignancies.

Rosanna established and directed the Pediatric Blood and Marrow Transplantation Program at Montefiore Medical Center, NY, where she held a faculty appointment for over 10 years. Rosanna led the clinical transplant program’s successful accreditation by the Foundation for the Accreditation of Cellular Therapy, recognition as a Children’s Oncology Group Transplant Center and membership to the National Marrow Donor Program and Pediatric Blood and Marrow Transplant Consortium. In addition, she was the Site PI and served on the NHL and HL Disease Committees of the Children’s Oncology Group.

Rosanna earned her Medical Doctorate at Mount Sinai School of Medicine and completed her fellowship training in Pediatric Hematology and Oncology at Memorial Sloan-Kettering Cancer Center in New York, where she remained as a research fellow in the Department of Human Genetics and Immunology working on gene transfer and adoptive cellular therapy strategies prior to joining the faculty at Montefiore in 2006.

Pin It on Pinterest

Scroll to Top